HucMSC-derived Exosomes Attenuate Colitis by Regulating Macrophage Pyroptosis Via the MiR-378a-5p/NLRP3 Axis

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2021 Jul 23

PMID 34294138

Citations 59

Authors

Xiu Cai

Zhi-Yu Zhang

Jin-Tao Yuan

Dickson Kofi Wiredu Ocansey

Qiang Tu

Xu Zhang

Hui Qian

Wen-Rong Xu

Wei Qiu

Fei Mao

Affiliations

Soon will be listed here.

Abstract

Background: Human umbilical cord mesenchymal stem cell (hucMSC)-derived exosomes are recognized as novel cell-free therapeutic agents for inflammatory bowel disease (IBD), a condition caused by dysregulated intestinal mucosal immunity. In this event, macrophage pyroptosis, a process of cell death following the activation of NLRP3 (NOD-like receptor family, pyrin domain-containing 3) inflammasomes, is believed to partially account for inflammatory reactions. However, the role of macrophage pyroptosis in the process of hucMSC-derived exosomes alleviating colitis remains unknown. This study aimed at exploring the therapeutic effect and mechanism of hucMSC-derived exosomes on colitis repair.

Methods: In vivo, we used BALB/c mice to establish a dextran sulfate sodium (DSS)-induced colitis model and administrated hucMSC-derived exosomes intravenously to estimate its curative effect. Human myeloid leukemia mononuclear (THP-1) cells and mouse peritoneal macrophages (MPMs) were stimulated with lipopolysaccharides (LPS) and Nigericin to activate NLRP3 inflammasomes, which simulated an inflammation environment in vitro. A microRNA mimic was used to verify the role of miR-378a-5p/NLRP3 axis in the colitis repair.

Results: hucMSC-derived exosomes inhibited the activation of NLRP3 inflammasomes in the mouse colon. The secretion of interleukin (IL)-18, IL-1β, and Caspase-1 cleavage was suppressed, resulting in reduced cell pyroptosis. The same outcome was observed in the in vitro cell experiments, where the co-culture of THP-1 cells and MPMs with hucMSC-derived exosomes caused decreased expression of NLRP3 inflammasomes and increased cell survival. Furthermore, miR-378a-5p was highly expressed in hucMSC-derived exosomes and played a vital function in colitis repair.

Conclusion: hucMSC-derived exosomes carrying miR-378a-5p inhibited NLRP3 inflammasomes and abrogated cell pyroptosis to protect against DSS-induced colitis.

Citing Articles

Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.

Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends.

Jiang H, Shao B, Wang H, Zhao W, Ren S, Xu Y Front Pharmacol. 2025; 15():1523052.

PMID: 39845796 PMC: 11750799. DOI: 10.3389/fphar.2024.1523052.

Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model.

Kheradmand F, Yasaman Rahimzadeh S, Esmaeili S, Negah S, Farkhad N, Nazari S Stem Cell Res Ther. 2025; 16(1):5.

PMID: 39773498 PMC: 11707839. DOI: 10.1186/s13287-024-04062-y.

Salivary exosomes exacerbate colitis by bridging the oral cavity and intestine.

Yang C, Chen J, Zhao Y, Wu J, Xu Y, Xu J iScience. 2025; 27(11):111061.

PMID: 39759079 PMC: 11700645. DOI: 10.1016/j.isci.2024.111061.

Fused extracellular vesicles from M macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis.

Liu Q, Ma T, Zhang Z, Nan J, Liu G, Yang Y J Extracell Vesicles. 2024; 13(12):e70028.

PMID: 39711510 PMC: 11664327. DOI: 10.1002/jev2.70028.

References

Wu X, Sun H, Luo Z, Cheng L, Duan X, Ren J . Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(5):165685. DOI: 10.1016/j.bbadis.2020.165685. View

Higashimori A, Watanabe T, Nadatani Y, Takeda S, Otani K, Tanigawa T . Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol. 2015; 9(3):659-68. DOI: 10.1038/mi.2015.89. View

Hass R, Kasper C, Bohm S, Jacobs R . Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011; 9:12. PMC: 3117820. DOI: 10.1186/1478-811X-9-12. View

Awad F, Assrawi E, Louvrier C, Jumeau C, Georgin-Lavialle S, Grateau G . Inflammasome biology, molecular pathology and therapeutic implications. Pharmacol Ther. 2018; 187:133-149. DOI: 10.1016/j.pharmthera.2018.02.011. View

Wu P, Zhang B, Shi H, Qian H, Xu W . MSC-exosome: A novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018; 20(3):291-301. DOI: 10.1016/j.jcyt.2017.11.002. View

Afonina I, Zhong Z, Karin M, Beyaert R . Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol. 2017; 18(8):861-869. DOI: 10.1038/ni.3772. View

Liu H, Liang Z, Wang F, Zhou C, Zheng X, Hu T . Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight. 2019; 4(24). PMC: 6975270. DOI: 10.1172/jci.insight.131273. View

Na Y, Stakenborg M, Seok S, Matteoli G . Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019; 16(9):531-543. DOI: 10.1038/s41575-019-0172-4. View

Liang C, Liu Y, Xu H, Huang J, Shen Y, Chen F . Exosomes of Human Umbilical Cord MSCs Protect Against Hypoxia/Reoxygenation-Induced Pyroptosis of Cardiomyocytes via the miRNA-100-5p/FOXO3/NLRP3 Pathway. Front Bioeng Biotechnol. 2021; 8:615850. PMC: 7844314. DOI: 10.3389/fbioe.2020.615850. View

10.

Petrilli V, Dostert C, Muruve D, Tschopp J . The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol. 2007; 19(6):615-22. DOI: 10.1016/j.coi.2007.09.002. View

11.

Rathinam V, Chan F . Inflammasome, Inflammation, and Tissue Homeostasis. Trends Mol Med. 2018; 24(3):304-318. PMC: 6456255. DOI: 10.1016/j.molmed.2018.01.004. View

12.

Sha R, Zhang B, Han X, Peng J, Zheng C, Zhang F . Electroacupuncture Alleviates Ischemic Brain Injury by Inhibiting the miR-223/NLRP3 Pathway. Med Sci Monit. 2019; 25:4723-4733. PMC: 6607941. DOI: 10.12659/MSM.917213. View

13.

Wallace K, Zheng L, Kanazawa Y, Shih D . Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014; 20(1):6-21. PMC: 3886033. DOI: 10.3748/wjg.v20.i1.6. View

14.

Xia C, Zeng Z, Fang B, Tao M, Gu C, Zheng L . Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med. 2019; 143:1-15. DOI: 10.1016/j.freeradbiomed.2019.07.026. View

15.

Toh W, Lai R, Hui J, Lim S . MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Semin Cell Dev Biol. 2016; 67:56-64. DOI: 10.1016/j.semcdb.2016.11.008. View

16.

Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson J, Tye H . Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017; 214(6):1737-1752. PMC: 5460990. DOI: 10.1084/jem.20160462. View

17.

Toh W, Lai R, Zhang B, Lim S . MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018; 46(4):843-853. PMC: 6103455. DOI: 10.1042/BST20180079. View

18.

Windsor J, Kaplan G . Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019; 21(8):40. DOI: 10.1007/s11894-019-0705-6. View

19.

Bauer C, Duewell P, Mayer C, Lehr H, Fitzgerald K, Dauer M . Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010; 59(9):1192-9. DOI: 10.1136/gut.2009.197822. View

20.

Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G . Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis. 2014; 8(10):1147-65. DOI: 10.1016/j.crohns.2014.03.008. View